Intrinsic Value of S&P & Nasdaq Contact Us

iAnthus Capital Holdings, Inc. ITHUF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
12/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

iAnthus Capital Holdings, Inc. (ITHUF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 12/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
12/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
29/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ITHUF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.20
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.32 $391.65K $-5.06M -1290.9%
2017 $-0.48 $2.41M $-13.72M -569.8%
2018 $-1.12 $3.41M $-71.48M -2099%
2019 $-1.90 $78.38M $-301.25M -384.3%
2020 $-1.81 $151.67M $-310.03M -204.4%
2021 $-0.44 $203.02M $-76.25M -37.6%
2022 $-0.07 $163.21M $-449.39M -275.3%
2023 $-0.01 $159.24M $-76.62M -48.1%
2024 $0.00 $167.57M $-7.64M -4.6%
2025 $-0.01 $143.99M $-40.91M -28.4%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message